The Smartspace Software (SMRT) share price has crashed. Here’s why

The SmartSpace share price has tanked. Roland Head drills into today’s profit warning and explains what’s gone wrong at this small-cap growth stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Shares in SmartSpace Software (LSE: SMRT) are down by 18%, at the time of writing. The stock crashed after the company warned that sales this year are likely to be lower than previously expected.

The group’s share price has now fallen by more than 50% from its June highs and is 15% lower than it was a year ago.

SmartSpace makes software used to manage office buildings, such as hot desking and meeting room booking systems. The company says that continued global uncertainty about when staff will return to the office is causing clients to delay purchase decisions.

The group’s partnership with Swedish firm Evoko appears to be a particular concern. Sales of the Evoko Naso room manager system — for which SmartSpace provides software — were expected to improve in the autumn. The company says Naso sales in September and early indications for October haven’t shown the expected growth.

As a result, SmartSpace now expects revenue to rise from £4.6m to just £5.2m during the current financial year. CEO Frank Beechinor expects to report an adjusted loss for the year of “not more than £2.7m”.

To put this in context, broker forecasts before today suggested SmartSpace would report revenue of £6.9m for the year, with a loss of £0.7m.

Still making progress?

Today’s update also included some details of SmartSpace’s recent trading. The company says that annual recurring revenue rose by 53% to £3.78m during the first half of this year, compared to the same period in 2020. And gross profit margins also improved, rising from 51% to 71%.

SmartSpace also said it expects stronger growth rates to resume when “business environments return to normal”.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »